Home » Starpharma to Advance With Phase III Studies for VivaGel
Starpharma to Advance With Phase III Studies for VivaGel
Starpharma has kicked off the year with a tick from the U.S. Food and Drug Administration for its study design for Phase III trials of VivaGel under the FDA’s Special Protocol Assessment scheme.
Australian Life Scientist
Australian Life Scientist
Upcoming Events
-
07May
-
14May
-
30May